After decades of attempts, FDA approves 1st vaccine for RSV

ViewAfter decades of scientific research, the first vaccine for respiratory syncytial virus (RSV), designed to protect older adults, has been approved by the United States.

Individuals aged 60 years and older can now use GSK’s vaccine, called Arexvy, to prevent lower respiratory tract disease (LRTD) resulting from RSV,...